Fri, Sep 19, 2014, 9:37 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Delcath Systems, Inc. Message Board

  • drwimax drwimax Feb 4, 2013 10:35 AM Flag

    Where is Delcath Headed?

    Now that China has seen that Celsion's ThermoDox with RF heat ablation doesn't work, they will now be jumping onboard with Delcath's Chemosat therapy. As reported, Asian countries have a very high incidence rate of liver cancer and currently have very few options in fighting this dreadful cancer.

    Delcath had amazing phase III trial results with Chemosat and when reported, investors jumped onboard quickly. During ASCO conference a dermatologist from Germany made very negative comments and the shorts decided to decimate the share price which they did, taking it from $16/share down to $2/share. This was so unfair to investors at the time. Now the time has come for Delcath to finally get their just rewards because unlike Celsion, their system really works and works extremely well.

    FDA approval is set for June, 2013 and it is pretty well certain that they will get it. Delcath already has achieved the CE mark in Europe so this will be the last hurdle for them. When China finally gives their approval, this stock will go into orbit.

    Good luck longs!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DCTH
2.18-0.11(-4.80%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.